// App-Quantinova.ai

1454 : IL-4 modulate the tumor microenvironment and response to cancer therapies

Researchers

Presenter

  • Shuku-ei A. Ito

Principal Investigators

  • Hidekazu Shirota

  • Chikashi Ishioka

Medical Centers

  • Tohoku University, Miyagi, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Interleukin 4

Drug/Treatment

  • Paclitaxel

  • IL-4

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A